Summary of advice for healthcare professionals looking after patients with immunodeficiency in the context of COVID-19.

Background

The UK Primary Immunodeficiency Network (UKPIN) has produced advice for healthcare professionals looking after patients with Immunodeficiency regarding COVID-19.

UKPIN advises healthcare professionals that:

  • It is recommended that Immunology services should still support the on-going provision of immunoglobulin replacement therapy for patients with immunodeficiency unless they are advised by their trust or national body that this is no longer possible.
  • Day unit attendance may be minimised in the following ways: starting antibiotic prophylaxis (to replace immunoglobulin therapy); changes to immunoglobulin dosing (by increasing interval); consideration of home therapy.

The document includes a table on risk stratification of patients with primary immunodeficiencies and secondary antibody deficiencies; the table details how various classes of medications used in these patient groups can affect their risk of harm from COVID-19.

Also provides a document on prioritisation of services if staffing/facilities have reduced capacity, which includes information on managing medicines such as IV immunoglobulin.

Have provided an update on COVID-19, the coronavirus vaccine and the shielding of  patients with primary immunodeficiency.

Change history

  1. Resources checked and information remains correct.
  1. Resources checked and information remains correct.
  1. Resources checked and information remains correct.
  1. Published